Immune-Cell-Based Therapy for COVID-19: Current Status.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
25 Oct 2023
Historique:
received: 19 08 2023
revised: 27 09 2023
accepted: 27 09 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. The interplay between innate and adaptive immune responses plays a crucial role in managing COVID-19. Cell therapy has recently emerged as a promising strategy to modulate the immune system, offering immense potential for the treatment of COVID-19 due to its customizability and regenerative capabilities. This review provides an overview of the various subsets of immune cell subsets implicated in the pathogenesis of COVID-19 and a comprehensive summary of the current status of immune cell therapy in COVID-19 treatment.

Identifiants

pubmed: 38005826
pii: v15112148
doi: 10.3390/v15112148
pmc: PMC10674523
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : 82173825
Organisme : National Natural Science Foundation of China
ID : 81973335

Références

Immunity. 2020 Oct 13;53(4):864-877.e5
pubmed: 32791036
Nature. 2023 Feb;614(7949):635-648
pubmed: 36813894
Clin Transl Med. 2021 Feb;11(2):e297
pubmed: 33634996
Blood. 2020 Dec 17;136(25):2905-2917
pubmed: 33331927
Curr Stem Cell Rep. 2022;8(2):72-92
pubmed: 35502223
Signal Transduct Target Ther. 2020 Aug 27;5(1):172
pubmed: 32855385
Life Sci Alliance. 2023 Mar 20;6(6):
pubmed: 36941056
Signal Transduct Target Ther. 2021 Feb 10;6(1):58
pubmed: 33568628
Stem Cells Transl Med. 2021 May;10(5):660-673
pubmed: 33400390
Stem Cells Int. 2020 Dec 18;2020:8892189
pubmed: 33414832
Nat Commun. 2021 Jul 27;12(1):4567
pubmed: 34315893
Annu Rev Immunol. 1999;17:189-220
pubmed: 10358757
Viruses. 2022 Jul 30;14(8):
pubmed: 36016311
EBioMedicine. 2022 Jan;75:103789
pubmed: 34963099
Front Immunol. 2023 Jan 30;14:1077236
pubmed: 36793739
Stem Cells Transl Med. 2021 Sep;10(9):1279-1287
pubmed: 34102020
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):
pubmed: 34433692
Nat Commun. 2022 May 11;13(1):2576
pubmed: 35546150
Bioengineering (Basel). 2022 Mar 07;9(3):
pubmed: 35324800
Lancet Respir Med. 2020 Aug;8(8):807-815
pubmed: 32422178
Nat Med. 2023 Aug;29(8):2019-2029
pubmed: 37460756
Am J Physiol Lung Cell Mol Physiol. 2012 May 15;302(10):L1003-13
pubmed: 22427530
Front Immunol. 2023 Jun 21;14:1200180
pubmed: 37415976
Cell Mol Immunol. 2021 Sep;18(9):2128-2139
pubmed: 34290398
Front Immunol. 2021 Dec 23;12:751869
pubmed: 35003063
Hum Immunol. 2022 Jan;83(1):86-98
pubmed: 34583856
Emerg Microbes Infect. 2023 Dec;12(1):2195019
pubmed: 36946172
Stem Cell Rev Rep. 2023 Feb;19(2):573-577
pubmed: 36271311
PLoS One. 2010 Feb 15;5(2):e9221
pubmed: 20169160
Immunity. 2023 Jul 11;56(7):1443-1450
pubmed: 37437537
Nat Med. 2022 Apr;28(4):678-689
pubmed: 35440724
Crit Care Explor. 2020 Sep 15;2(9):e0207
pubmed: 32984833
Cell. 2020 Nov 25;183(5):1340-1353.e16
pubmed: 33096020
Adv Drug Deliv Rev. 2021 Dec;179:114003
pubmed: 34653533
Front Bioeng Biotechnol. 2022 Apr 04;10:867042
pubmed: 35480981
J Leukoc Biol. 2002 Mar;71(3):445-57
pubmed: 11867682
Cell Transplant. 2021 Jan-Dec;30:9636897211024942
pubmed: 34180719
Nat Rev Immunol. 2023 Oct;23(10):618-634
pubmed: 37433988
Ann Intern Med. 2020 Nov 17;173(10):852-853
pubmed: 32628535
Front Immunol. 2022 Jul 08;13:916411
pubmed: 35874688
Front Immunol. 2019 May 22;10:1124
pubmed: 31191520
Int Immunopharmacol. 2022 Jun;107:108655
pubmed: 35248946
Nature. 2020 Nov;587(7835):555-566
pubmed: 33239795
J Immunol. 2008 Oct 15;181(8):5490-500
pubmed: 18832706
Aging Dis. 2020 Mar 9;11(2):216-228
pubmed: 32257537
Rev Med Virol. 2021 Jul;31(4):e2195
pubmed: 34260780
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
Allergy. 2022 Jan;77(1):100-110
pubmed: 34245591
Blood. 2020 Nov 12;136(20):2308-2318
pubmed: 32614951
Cell Host Microbe. 2020 Jun 10;27(6):870-878
pubmed: 32464097
Hum Vaccin Immunother. 2022 Nov 30;18(5):2055945
pubmed: 35404743
Cell Rep Med. 2020 May 19;1(2):100016
pubmed: 32562483
Life Sci. 2018 Nov 1;212:203-212
pubmed: 30287233
Lancet Respir Med. 2023 Aug;11(8):709-725
pubmed: 37216955
Front Immunol. 2020 May 19;11:1091
pubmed: 32574263
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Cell Mol Immunol. 2020 May;17(5):533-535
pubmed: 32203188
Science. 2022 Mar 11;375(6585):1122-1127
pubmed: 35271343
Nat Rev Microbiol. 2023 Jun;21(6):361-379
pubmed: 37020110
J Leukoc Biol. 2008 Jul;84(1):1-26
pubmed: 18388298
Immunity. 2021 Jun 8;54(6):1186-1199.e7
pubmed: 33915108
Signal Transduct Target Ther. 2020 Dec 4;5(1):283
pubmed: 33277466
Front Immunol. 2021 Jan 08;11:598402
pubmed: 33488592
EClinicalMedicine. 2021 Sep;39:101086
pubmed: 34405140
Immunology. 2023 Apr;168(4):684-696
pubmed: 36349514
Front Immunol. 2023 Jun 19;14:1195871
pubmed: 37404823
Br J Haematol. 2020 Aug;190(4):e185-e187
pubmed: 32480418
Stem Cell Res Ther. 2020 Aug 18;11(1):361
pubmed: 32811531
J Virol. 2019 Feb 19;93(5):
pubmed: 30541850
Cell Rep. 2021 Jul 20;36(3):109432
pubmed: 34270918
PLoS Pathog. 2021 Oct 6;17(10):e1009742
pubmed: 34614036
Nat Rev Microbiol. 2023 Mar;21(3):162-177
pubmed: 36653446
J Cell Mol Med. 2021 Nov;25(22):10554-10564
pubmed: 34632708
Sci Adv. 2021 Nov 12;7(46):eabj0274
pubmed: 34757794
Trends Immunol. 2021 Jan;42(1):18-30
pubmed: 33277181
Cell Immunol. 2023 Apr;386:104691
pubmed: 36822152
Annu Rev Immunol. 2001;19:65-91
pubmed: 11244031
Signal Transduct Target Ther. 2021 Jan 20;6(1):26
pubmed: 33473101
Biologics. 2012;6:73-82
pubmed: 22532775
Aging Dis. 2020 Mar 9;11(2):462-464
pubmed: 32257554
Int Immunopharmacol. 2021 Aug;97:107828
pubmed: 34091116
Bioengineering (Basel). 2022 Nov 08;9(11):
pubmed: 36354573
Immunity. 2023 May 9;56(5):909-913
pubmed: 37105169
Stem Cells Transl Med. 2020 Jul;9(7):813-814
pubmed: 32320535
Pain Physician. 2020 Mar;23(2):E71-E83
pubmed: 32214286

Auteurs

Yiyuan Wang (Y)

Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Qinghe Liang (Q)

Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Fengsheng Chen (F)

Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Jiehuang Zheng (J)

Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Yan Chen (Y)

Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Ziye Chen (Z)

Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Ruopeng Li (R)

Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Xiaojuan Li (X)

Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH